NYSE:HLTH
Delisted
Nobilis Health Corp Stock News
$0.123
+0 (+0%)
At Close: Sep 20, 2019
3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter
08:49pm, Monday, 18'th Mar 2024
Listen, if you haven't gotten the memo, penny stocks are incredibly dangerous. Yes, they're cheap – in this case, extremely cheap.
Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates
06:10pm, Wednesday, 13'th Mar 2024
Cue Health Inc. (HLTH) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.50 per share a year ago.
Cue Health Inc. (HLTH) Q3 2023 Earnings Call Transcript
11:43pm, Wednesday, 08'th Nov 2023
Cue Health Inc. (NASDAQ:HLTH ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Lorna Williams - Investor Relations Ayub Khattak - Chairman, President and Chief Execut
Cue Health to Announce Third Quarter 2023 Financial Results
04:01pm, Wednesday, 25'th Oct 2023
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2023 financial results on Wednesday, Nov
Cue Health Inc. (HLTH) Q2 2023 Earnings Call Transcript
10:17pm, Wednesday, 09'th Aug 2023
Cue Health Inc. (NASDAQ:HLTH ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman Aasim Javed - CF
Cue Health Inc. (HLTH) Reports Q2 Loss, Tops Revenue Estimates
06:59pm, Wednesday, 09'th Aug 2023
Cue Health Inc. (HLTH) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.37 per share a year ago.
US FDA approves Cue Health's at-home COVID test
03:32pm, Tuesday, 06'th Jun 2023
The U.S. Food and Drug Administration on Tuesday approved Cue Health's at-home COVID-19 test, the first coronavirus test to get marketing authorization using a traditional premarket review, the agency
Cue Health Inc. (HLTH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
11:05am, Monday, 29'th May 2023
Cue Health Inc. (HLTH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement amon
Cue Health Inc. (HLTH) Upgraded to Buy: Here's What You Should Know
01:33pm, Wednesday, 17'th May 2023
Cue Health Inc. (HLTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cue Health Inc. (HLTH) Loses -47.82% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11:17am, Wednesday, 17'th May 2023
Cue Health Inc. (HLTH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in re
Cue Health, Inc. (HLTH) Q1 2023 Earnings Call Transcript
08:49pm, Wednesday, 10'th May 2023
Cue Health, Inc. (NASDAQ:HLTH ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman Aasim Javed - CFO
Cue Health to Announce First Quarter 2023 Financial Results
04:01pm, Wednesday, 26'th Apr 2023
SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May
Cue Health, Inc. (HLTH) Q4 2022 Earnings Call Transcript
10:32pm, Wednesday, 15'th Mar 2023
Cue Health, Inc. (NASDAQ:HLTH ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Lorna Williams - IR Ayub Khattak - Co-Founder, President, CEO & Chairman Aasim Javed - C
Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
06:43pm, Wednesday, 01'st Feb 2023 Benzinga
Gainers
Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit manageme
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
06:01pm, Thursday, 05'th Jan 2023 Benzinga
Gainers
Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercializatio